Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AIDS/HIV Vaccine
Therapeutic HIV vaccines reviewed
December 12th, 2004
Scientists review therapeutic AIDS/HIV vaccines in a recent issue of the journal Vaccine. According to a study from, "The goal of a therapeutic HIV vaccine is to attenuate HIV disease progression in those already infected. Our objective was to establish comparative efficacy and cost-effectiveness thresholds at which a therapeutic vaccine would make a valuable contribution to HIV care. Using an HIV computer simulation model, we compared therapeutic vaccination with HIV standard of care without vaccination. Input data were obtained from the literature." "Base case and sensitivity analyses related to vaccine magnitude, penetrance, durability, and...
Source: Medical Letter on the CDC & FDA (2004-12-12)
|
